 | • レポートコード：MRC23Q35821 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（2-3日） • 産業分類：新技術 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の生化学ベフェンス市場について調査・分析し、世界の生化学ベフェンス市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（炭疽菌、天然痘、ボツリヌス中毒症、放射線・核、その他）、用途別セグメント分析（国防、軍事）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Emergent Biosolutions、Hytest、GSK、Sanofi、PharmAthene、Bavarian Nordic、SIGA Technologies、Arbutus Biopharma、DynPort Vaccine、Xoma Corporation、Ichor Medical Systems、Aeolus Pharmaceuticals、Achaogen、Elusys Therapeutics、Dynavax Technologies、Cleveland BioLabs、Soligenix、Alnylam Pharmaceuticalsなどが含まれています。世界の生化学ベフェンス市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、生化学ベフェンス市場規模を推定する際に考慮しました。本レポートは、生化学ベフェンスの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、生化学ベフェンスに関するビジネス上の意思決定に役立てることを目的としています。 ・生化学ベフェンス市場の概要 - 生化学ベフェンスのタイプ別セグメント - 世界の生化学ベフェンス市場規模：タイプ別分析（炭疽菌、天然痘、ボツリヌス中毒症、放射線・核、その他） - 生化学ベフェンスの用途別セグメント - 世界の生化学ベフェンス市場規模：用途別分析（国防、軍事） - 世界の生化学ベフェンス市場規模予測（2018年-2029年） ・生化学ベフェンス市場の成長トレンド - 生化学ベフェンスの地域別市場規模（2018年-2029年） - 生化学ベフェンス市場ダイナミクス - 生化学ベフェンスの業界動向 - 生化学ベフェンス市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：炭疽菌、天然痘、ボツリヌス中毒症、放射線・核、その他 - 世界の生化学ベフェンスのタイプ別市場規模（2018年-2023年） - 世界の生化学ベフェンスのタイプ別市場規模（2024年-2029年） ・用途別セグメント：国防、軍事 - 世界の生化学ベフェンスの用途別市場規模（2018年-2023年） - 世界の生化学ベフェンスの用途別市場規模（2024年-2029年） ・生化学ベフェンスの地域別市場規模 - 北米の生化学ベフェンス市場規模（2018年-2029年） - アメリカの生化学ベフェンス市場規模（2018年-2029年） - ヨーロッパの生化学ベフェンス市場規模（2018年-2029年） - アジア太平洋の生化学ベフェンス市場規模（2018年-2029年） - 中国の生化学ベフェンス市場規模（2018年-2029年） - 日本の生化学ベフェンス市場規模（2018年-2029年） - 韓国の生化学ベフェンス市場規模（2018年-2029年） - インドの生化学ベフェンス市場規模（2018年-2029年） - オーストラリアの生化学ベフェンス市場規模（2018年-2029年） - 中南米の生化学ベフェンス市場規模（2018年-2029年） - 中東・アフリカの生化学ベフェンス市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Emergent Biosolutions、Hytest、GSK、Sanofi、PharmAthene、Bavarian Nordic、SIGA Technologies、Arbutus Biopharma、DynPort Vaccine、Xoma Corporation、Ichor Medical Systems、Aeolus Pharmaceuticals、Achaogen、Elusys Therapeutics、Dynavax Technologies、Cleveland BioLabs、Soligenix、Alnylam Pharmaceuticals ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Biochemical Befense market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Biochemical Befense is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Biochemical Befense is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Biochemical Befense in National Defense is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Biochemical Befense include Emergent Biosolutions, Hytest, GSK, Sanofi, PharmAthene, Bavarian Nordic, SIGA Technologies, Arbutus Biopharma and DynPort Vaccine, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Biochemical Befense, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biochemical Befense.
The Biochemical Befense market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Biochemical Befense market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biochemical Befense companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Emergent Biosolutions
Hytest
GSK
Sanofi
PharmAthene
Bavarian Nordic
SIGA Technologies
Arbutus Biopharma
DynPort Vaccine
Xoma Corporation
Ichor Medical Systems
Aeolus Pharmaceuticals
Achaogen
Elusys Therapeutics
Dynavax Technologies
Cleveland BioLabs
Soligenix
Alnylam Pharmaceuticals
Segment by Type
Anthrax
Smallpox
Botulism
Radiation/Nuclear
Other
Segment by Application
National Defense
Military
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biochemical Befense companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biochemical Befense Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Anthrax
1.2.3 Smallpox
1.2.4 Botulism
1.2.5 Radiation/Nuclear
1.2.6 Other
1.3 Market by Application
1.3.1 Global Biochemical Befense Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 National Defense
1.3.3 Military
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biochemical Befense Market Perspective (2018-2029)
2.2 Biochemical Befense Growth Trends by Region
2.2.1 Global Biochemical Befense Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Biochemical Befense Historic Market Size by Region (2018-2023)
2.2.3 Biochemical Befense Forecasted Market Size by Region (2024-2029)
2.3 Biochemical Befense Market Dynamics
2.3.1 Biochemical Befense Industry Trends
2.3.2 Biochemical Befense Market Drivers
2.3.3 Biochemical Befense Market Challenges
2.3.4 Biochemical Befense Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biochemical Befense Players by Revenue
3.1.1 Global Top Biochemical Befense Players by Revenue (2018-2023)
3.1.2 Global Biochemical Befense Revenue Market Share by Players (2018-2023)
3.2 Global Biochemical Befense Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biochemical Befense Revenue
3.4 Global Biochemical Befense Market Concentration Ratio
3.4.1 Global Biochemical Befense Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biochemical Befense Revenue in 2022
3.5 Biochemical Befense Key Players Head office and Area Served
3.6 Key Players Biochemical Befense Product Solution and Service
3.7 Date of Enter into Biochemical Befense Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biochemical Befense Breakdown Data by Type
4.1 Global Biochemical Befense Historic Market Size by Type (2018-2023)
4.2 Global Biochemical Befense Forecasted Market Size by Type (2024-2029)
5 Biochemical Befense Breakdown Data by Application
5.1 Global Biochemical Befense Historic Market Size by Application (2018-2023)
5.2 Global Biochemical Befense Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Biochemical Befense Market Size (2018-2029)
6.2 North America Biochemical Befense Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Biochemical Befense Market Size by Country (2018-2023)
6.4 North America Biochemical Befense Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biochemical Befense Market Size (2018-2029)
7.2 Europe Biochemical Befense Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Biochemical Befense Market Size by Country (2018-2023)
7.4 Europe Biochemical Befense Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biochemical Befense Market Size (2018-2029)
8.2 Asia-Pacific Biochemical Befense Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Biochemical Befense Market Size by Region (2018-2023)
8.4 Asia-Pacific Biochemical Befense Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biochemical Befense Market Size (2018-2029)
9.2 Latin America Biochemical Befense Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Biochemical Befense Market Size by Country (2018-2023)
9.4 Latin America Biochemical Befense Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biochemical Befense Market Size (2018-2029)
10.2 Middle East & Africa Biochemical Befense Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Biochemical Befense Market Size by Country (2018-2023)
10.4 Middle East & Africa Biochemical Befense Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Emergent Biosolutions
11.1.1 Emergent Biosolutions Company Detail
11.1.2 Emergent Biosolutions Business Overview
11.1.3 Emergent Biosolutions Biochemical Befense Introduction
11.1.4 Emergent Biosolutions Revenue in Biochemical Befense Business (2018-2023)
11.1.5 Emergent Biosolutions Recent Development
11.2 Hytest
11.2.1 Hytest Company Detail
11.2.2 Hytest Business Overview
11.2.3 Hytest Biochemical Befense Introduction
11.2.4 Hytest Revenue in Biochemical Befense Business (2018-2023)
11.2.5 Hytest Recent Development
11.3 GSK
11.3.1 GSK Company Detail
11.3.2 GSK Business Overview
11.3.3 GSK Biochemical Befense Introduction
11.3.4 GSK Revenue in Biochemical Befense Business (2018-2023)
11.3.5 GSK Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Detail
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Biochemical Befense Introduction
11.4.4 Sanofi Revenue in Biochemical Befense Business (2018-2023)
11.4.5 Sanofi Recent Development
11.5 PharmAthene
11.5.1 PharmAthene Company Detail
11.5.2 PharmAthene Business Overview
11.5.3 PharmAthene Biochemical Befense Introduction
11.5.4 PharmAthene Revenue in Biochemical Befense Business (2018-2023)
11.5.5 PharmAthene Recent Development
11.6 Bavarian Nordic
11.6.1 Bavarian Nordic Company Detail
11.6.2 Bavarian Nordic Business Overview
11.6.3 Bavarian Nordic Biochemical Befense Introduction
11.6.4 Bavarian Nordic Revenue in Biochemical Befense Business (2018-2023)
11.6.5 Bavarian Nordic Recent Development
11.7 SIGA Technologies
11.7.1 SIGA Technologies Company Detail
11.7.2 SIGA Technologies Business Overview
11.7.3 SIGA Technologies Biochemical Befense Introduction
11.7.4 SIGA Technologies Revenue in Biochemical Befense Business (2018-2023)
11.7.5 SIGA Technologies Recent Development
11.8 Arbutus Biopharma
11.8.1 Arbutus Biopharma Company Detail
11.8.2 Arbutus Biopharma Business Overview
11.8.3 Arbutus Biopharma Biochemical Befense Introduction
11.8.4 Arbutus Biopharma Revenue in Biochemical Befense Business (2018-2023)
11.8.5 Arbutus Biopharma Recent Development
11.9 DynPort Vaccine
11.9.1 DynPort Vaccine Company Detail
11.9.2 DynPort Vaccine Business Overview
11.9.3 DynPort Vaccine Biochemical Befense Introduction
11.9.4 DynPort Vaccine Revenue in Biochemical Befense Business (2018-2023)
11.9.5 DynPort Vaccine Recent Development
11.10 Xoma Corporation
11.10.1 Xoma Corporation Company Detail
11.10.2 Xoma Corporation Business Overview
11.10.3 Xoma Corporation Biochemical Befense Introduction
11.10.4 Xoma Corporation Revenue in Biochemical Befense Business (2018-2023)
11.10.5 Xoma Corporation Recent Development
11.11 Ichor Medical Systems
11.11.1 Ichor Medical Systems Company Detail
11.11.2 Ichor Medical Systems Business Overview
11.11.3 Ichor Medical Systems Biochemical Befense Introduction
11.11.4 Ichor Medical Systems Revenue in Biochemical Befense Business (2018-2023)
11.11.5 Ichor Medical Systems Recent Development
11.12 Aeolus Pharmaceuticals
11.12.1 Aeolus Pharmaceuticals Company Detail
11.12.2 Aeolus Pharmaceuticals Business Overview
11.12.3 Aeolus Pharmaceuticals Biochemical Befense Introduction
11.12.4 Aeolus Pharmaceuticals Revenue in Biochemical Befense Business (2018-2023)
11.12.5 Aeolus Pharmaceuticals Recent Development
11.13 Achaogen
11.13.1 Achaogen Company Detail
11.13.2 Achaogen Business Overview
11.13.3 Achaogen Biochemical Befense Introduction
11.13.4 Achaogen Revenue in Biochemical Befense Business (2018-2023)
11.13.5 Achaogen Recent Development
11.14 Elusys Therapeutics
11.14.1 Elusys Therapeutics Company Detail
11.14.2 Elusys Therapeutics Business Overview
11.14.3 Elusys Therapeutics Biochemical Befense Introduction
11.14.4 Elusys Therapeutics Revenue in Biochemical Befense Business (2018-2023)
11.14.5 Elusys Therapeutics Recent Development
11.15 Dynavax Technologies
11.15.1 Dynavax Technologies Company Detail
11.15.2 Dynavax Technologies Business Overview
11.15.3 Dynavax Technologies Biochemical Befense Introduction
11.15.4 Dynavax Technologies Revenue in Biochemical Befense Business (2018-2023)
11.15.5 Dynavax Technologies Recent Development
11.16 Cleveland BioLabs
11.16.1 Cleveland BioLabs Company Detail
11.16.2 Cleveland BioLabs Business Overview
11.16.3 Cleveland BioLabs Biochemical Befense Introduction
11.16.4 Cleveland BioLabs Revenue in Biochemical Befense Business (2018-2023)
11.16.5 Cleveland BioLabs Recent Development
11.17 Soligenix
11.17.1 Soligenix Company Detail
11.17.2 Soligenix Business Overview
11.17.3 Soligenix Biochemical Befense Introduction
11.17.4 Soligenix Revenue in Biochemical Befense Business (2018-2023)
11.17.5 Soligenix Recent Development
11.18 Alnylam Pharmaceuticals
11.18.1 Alnylam Pharmaceuticals Company Detail
11.18.2 Alnylam Pharmaceuticals Business Overview
11.18.3 Alnylam Pharmaceuticals Biochemical Befense Introduction
11.18.4 Alnylam Pharmaceuticals Revenue in Biochemical Befense Business (2018-2023)
11.18.5 Alnylam Pharmaceuticals Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
